Predator Profile: NOVARTIS

NOVARTIS

Novartis is the result of the ongoing concentration of the Swiss pharmaceutical and chemical industries. It was formed in 1996 through the merger of Ciba-Geigy and Sandoz, which had earlier in their existence both been part of the Basel cartel formed after the First World War. Before and after the merger, the businesses that went into the creation of Novartis were frequently at the center of controversies concerning unsafe drugs and pesticides, price-gouging, improper marketing and toxic dumping. Novartis was widely criticized for its drawn-out but ultimately unsuccessful battle against an Indian patent policy designed to make lower-cost drugs more widely available in poor countries.


 

NOVARTIS – RAP SHEET

Corp-Research.org – Predatory behavior and violations. Complete inventory.


General Profile Data on NOVARTIS

Website
Board of Directors
Company Profile
Financials


Sources of Interest

Novartis to pay $42 Million in Civil, Criminal Penalties

Novartis Vaccines & Diagnostics to Pay More Than $72 Million to Resolve False Claims Act

Healthcare Fraud Lawsuit Filed Against Novartis For Orchestrating A Multi-Million Dollar Prescription Drug Kickback Scheme

Corporate Research Project: NOVARTIS


Reading

Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients

Selling Sickness: How the World’s Biggest Pharmaceutical Companies Are Turning Us All Into Patients

The Truth About the Drug Companies: How They Deceive Us and What to Do About It

Overdosed America: The Broken Promise of American Medicine


“In the U.S., our health care system is based on the premise that health care is a commodity like VCRs or computers and that it should be distributed according to the ability to pay in the same way that consumer goods are. That’s not what health care should be. Health care is a need; it’s not a commodity, and it should be distributed according to need. If you’re very sick, you should have a lot of it. If you’re not sick, you shouldn’t have a lot of it. But this should be seen as a personal, individual need, not as a commodity to be distributed like other marketplace commodities. That is a fundamental mistake in the way this country, and only this country, looks at health care. And that market ideology is what has made the health care system so dreadful, so bad at what it does.”

Marcia Angell, M, author of “The Truth About the Drug Companies: How They Deceive Us and What to Do About It”


More Pharma Profiles

PROFILE PAGE – MERCK

PROFILE PAGE – GLAXO SMITH KLINE

PROFILE PAGE – ELI LILLY

PROFILE PAGE – NOVARTIS

PROFILE PAGE – PFIZER

PROFILE PAGE – ASTRAZENECA

PROFILE PAGE – ABBOTT RESEARCH

PROFILE PAGE – JOHNSON JOHNSON

PROFILE PAGE – GSK – CHAIR